First results with the new Fresenius cell separator AS 104

V. Kretschmer , A. See , D. Söhngen , M. Bachem , J.G. Kadar , H. Borberg , H. Pelzer , P. Zöfel
{"title":"First results with the new Fresenius cell separator AS 104","authors":"V. Kretschmer ,&nbsp;A. See ,&nbsp;D. Söhngen ,&nbsp;M. Bachem ,&nbsp;J.G. Kadar ,&nbsp;H. Borberg ,&nbsp;H. Pelzer ,&nbsp;P. Zöfel","doi":"10.1016/S0278-6222(87)80035-9","DOIUrl":null,"url":null,"abstract":"<div><p>In the last few years Fresenius has developed a new cell separator. The intention was to improve the existing systems by taking advantage of the extensive worldwide experience of cell separation in the past years. The first prototypes of this cell separator AS 104 were set up in Marburg and in Cologne. In a pilot study we performed 25 procedures with 2 to 3 liters of fresh whole blood. These results will not be considered here. We now present the results from the first clinical trial.</p></div>","PeriodicalId":101030,"journal":{"name":"Plasma Therapy and Transfusion Technology","volume":"8 4","pages":"Pages 298-301"},"PeriodicalIF":0.0000,"publicationDate":"1987-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0278-6222(87)80035-9","citationCount":"15","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Plasma Therapy and Transfusion Technology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0278622287800359","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 15

Abstract

In the last few years Fresenius has developed a new cell separator. The intention was to improve the existing systems by taking advantage of the extensive worldwide experience of cell separation in the past years. The first prototypes of this cell separator AS 104 were set up in Marburg and in Cologne. In a pilot study we performed 25 procedures with 2 to 3 liters of fresh whole blood. These results will not be considered here. We now present the results from the first clinical trial.

新费森尤斯细胞分离器as104的初步结果
在过去的几年里,费森尤斯开发了一种新的细胞分离器。其目的是利用过去几年世界范围内广泛的细胞分离经验来改进现有的系统。这种细胞分离器as104的第一个原型是在马尔堡和科隆建立的。在一项初步研究中,我们用2到3升新鲜全血进行了25次手术。这里不考虑这些结果。我们现在公布第一次临床试验的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信